Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (441-450 of 470) with videos related to

Pageof 47
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2025
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier DysfunctionRabina Giri, Minyi Lee, Graham W Magor, et al.
Anesthesia and Analgesia|November 29, 2007
Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomitingTong J Gan, Tricia A Meyer, Christian C Apfel, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 2. Assessing the appropriateness of the healthcare delivered to Australian children: study protocol for a retrospective medical record reviewTamara D Hooper, Peter D Hibbert, Nicole Mealing, et al.
British Journal of Cancer|January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cellsEsha T Shah, Christopher Molloy, Madeline Gough, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 1. Assessing the appropriateness of healthcare delivered to Australian children: study protocol for clinical indicator developmentLouise K Wiles, Tamara D Hooper, Peter D Hibbert, et al.
Cell Death & Disease|January 8, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cellsShivam Vora, Saptarshi Chatterjee, Ariel Andrew, et al.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Contrast Media & Molecular Imaging|October 8, 2021
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal CancerTahleesa J Cuda, Yaowu He, Thomas Kryza, et al.
Nursing Outlook|September 13, 2024
Call to action: Blueprint for change in acute and critical care nursingMartha A Q Curley, Margarete L Zalon, Maureen A Seckel, et al.
Journal of Occupational and Environmental Medicine|March 26, 2021
Invasive Treatments for Low Back DisordersKurt T Hegmann, Russell Travis, Gunnar B J Andersson, et al.
Pageof 47

Showing results (441-450 of 470) with videos related to

Sort By:
Pageof 47
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2025
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier DysfunctionRabina Giri, Minyi Lee, Graham W Magor, et al.
Anesthesia and Analgesia|November 29, 2007
Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomitingTong J Gan, Tricia A Meyer, Christian C Apfel, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 2. Assessing the appropriateness of the healthcare delivered to Australian children: study protocol for a retrospective medical record reviewTamara D Hooper, Peter D Hibbert, Nicole Mealing, et al.
British Journal of Cancer|January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cellsEsha T Shah, Christopher Molloy, Madeline Gough, et al.
BMJ Open|April 10, 2015
CareTrack Kids-part 1. Assessing the appropriateness of healthcare delivered to Australian children: study protocol for clinical indicator developmentLouise K Wiles, Tamara D Hooper, Peter D Hibbert, et al.
Cell Death & Disease|January 8, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cellsShivam Vora, Saptarshi Chatterjee, Ariel Andrew, et al.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Contrast Media & Molecular Imaging|October 8, 2021
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal CancerTahleesa J Cuda, Yaowu He, Thomas Kryza, et al.
Nursing Outlook|September 13, 2024
Call to action: Blueprint for change in acute and critical care nursingMartha A Q Curley, Margarete L Zalon, Maureen A Seckel, et al.
Journal of Occupational and Environmental Medicine|March 26, 2021
Invasive Treatments for Low Back DisordersKurt T Hegmann, Russell Travis, Gunnar B J Andersson, et al.
Pageof 47